Chromadex Corp. (CDXC) Stock Recommendation | Score, Valuation, Technicals & Financial Trend

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

Comparison

Company

Score

Quality

Valuation

Financial

Technical

USANA Health Sciences, Inc.

Nature's Sunshine Products, Inc.

Chromadex Corp.

ProPhase Labs, Inc.

LifeVantage Corp.

Natural Alternatives International, Inc.

Upexi, Inc.

Revolution Medicines, Inc.

MIRA Pharmaceuticals, Inc.

Bright Green Corp.

Cidara Therapeutics, Inc.

Why is Chromadex Corp. ?

Poor Management Efficiency with a low ROE of 5.86%

The company has been able to generate a Return on Equity (avg) of 5.86% signifying low profitability per unit of shareholders funds

Negative results in Jun 26

DEBT-EQUITY RATIO (HY) Highest at -78.05 %
INVENTORY TURNOVER RATIO(HY) Lowest at 2.63 times
NET SALES(Q) Lowest at USD 29.79 MM

Underperformed the market in the last 1 year

Even though the market (S&P 500) has generated returns of 15.36% in the last 1 year, the stock has hugely underperformed and has generate negative returns of -70.51% returns

Real-Time Research Report

Verdict Report

How much should you sell?

All quantity irrespective of whether you are making profits or losses

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to re-enter? - We will constantly monitor the company and review our call based on new data

Is Chromadex Corp. for you?

High Risk, Low Return

Absolute

Risk Adjusted

Volatility

Chromadex Corp.

-70.51%

-0.06

50.64%

S&P 500

15.36%

1.17

13.09%

Quality

Management Risk

Growth

Capital Structure

Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor

Value

Sales Growth (5y)

16.91%

EBIT Growth (5y)

26.75%

EBIT to Interest (avg)

-3.81

Debt to EBITDA (avg)

Negative Net Debt

Net Debt to Equity (avg)

-0.99

Sales to Capital Employed (avg)

2.31

Tax Ratio

3.24%

Dividend Payout Ratio

Pledged Shares

Institutional Holding

51.28%

ROCE (avg)

306.58%

ROE (avg)

5.86%

Valuation

Valuation Scorecard

Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors

Factor

Value

P/E Ratio

Industry P/E

Price to Book Value

4.39

EV to EBIT

19.06

EV to EBITDA

17.31

EV to Capital Employed

21.38

EV to Sales

2.11

PEG Ratio

0.42

Dividend Yield

ROCE (Latest)

112.15%

ROE (Latest)

22.71%

Technicals

Technical key factors

Indicator

Weekly

Monthly

MACD

Mildly Bullish

Mildly Bearish

RSI

No Signal

Bollinger Bands

Mildly Bearish

Moving Averages

Bearish (Daily)

KST

Bearish

Mildly Bearish

Dow Theory

Mildly Bullish

No Trend

OBV

Mildly Bullish

No Trend

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Technical Movement

Analyse All Technical Factors

Financial Trend

Financial Trend Scorecard

Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

2What is working for the Company

RAW MATERIAL COST(Y)

Fallen by 0.25% (YoY

CASH AND EQV(HY)

Highest at USD 133.29 MM

-17What is not working for the Company

DEBT-EQUITY RATIO (HY)

Highest at -78.05 %

INVENTORY TURNOVER RATIO(HY)

Lowest at 2.63 times

NET SALES(Q)

Lowest at USD 29.79 MM

OPERATING PROFIT(Q)

Lowest at USD 1.17 MM

OPERATING PROFIT MARGIN(Q)

Lowest at 3.93 %

PRE-TAX PROFIT(Q)

Lowest at USD 1.07 MM

NET PROFIT(Q)

Lowest at USD 0.96 MM

EPS(Q)

Lowest at USD 0.01

Here's what is working for Chromadex Corp.

Cash and Eqv

Highest at USD 133.29 MM

in the last six Semi-Annual periods

MOJO Watch

Short Term liquidity is improving

Cash and Cash Equivalents

Raw Material Cost

Fallen by 0.25% (YoY)

MOJO Watch

The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin

Raw Material Cost as a percentage of Sales

Here's what is not working for Chromadex Corp.

Pre-Tax Profit

At USD 1.07 MM has Fallen at -78.29%

over average net sales of the previous four periods of USD 4.92 MM

MOJO Watch

Near term Pre-Tax Profit trend is very negative

Pre-Tax Profit (USD MM)

Net Profit

At USD 0.96 MM has Fallen at -79.33%

over average net sales of the previous four periods of USD 4.66 MM

MOJO Watch

Near term Net Profit trend is very negative

Net Profit (USD MM)

Net Sales

Lowest at USD 29.79 MM

in the last five periods

MOJO Watch

Near term sales trend is negative

Net Sales (USD MM)

Net Sales

At USD 29.79 MM has Fallen at -8.65%

over average net sales of the previous four periods of USD 32.6 MM

MOJO Watch

Near term sales trend is negative

Net Sales (USD MM)

Operating Profit

Lowest at USD 1.17 MM

in the last five periods

MOJO Watch

Near term Operating Profit trend is negative

Operating Profit (USD MM)

Operating Profit Margin

Lowest at 3.93 %

in the last five periods

MOJO Watch

Company's profit margin has deteriorated

Operating Profit to Sales

Pre-Tax Profit

Lowest at USD 1.07 MM

in the last five periods

MOJO Watch

Near term Pre-Tax Profit trend is negative

Pre-Tax Profit (USD MM)

Net Profit

Lowest at USD 0.96 MM

in the last five periods

MOJO Watch

Near term Net Profit trend is negative

Net Profit (USD MM)

EPS

Lowest at USD 0.01

in the last five periods

MOJO Watch

Declining profitability; company has created lower earnings for shareholders

EPS (USD)

Debt-Equity Ratio

Highest at -78.05 %

in the last five Semi-Annual periods

MOJO Watch

The company is borrowing more to fund its operations; it's liquidity situation may be stressed

Debt-Equity Ratio

Inventory Turnover Ratio

Lowest at 2.63 times

in the last five Semi-Annual periods

MOJO Watch

Company's pace of selling inventory has slowed

Inventory Turnover Ratio